Medication info
Zacutex 625mg (Amoxicillin·Clavulanate Potassium)

Zacutex 625mg (Amoxicillin·Clavulanate Potassium)

Prescription medicationTabletOral
Ingredient · strength
Amoxicillin Hydrate›500mg / 1 tabletDilute Potassium Clavulanate›212.73mg / 1 tablet
Manufacturer / importer
Teragen Etex Co., Ltd.
Appearance
White to nearly white oval film-coated tablets
Packaging
40 tablets/box [(4 tablets/PTP X 10)]
Approval status
Active

MFDS item code 200201927 · Notified 2002.03.04 · Insurance code 698500510

Summary

Main use
Treatment of respiratory tract infections, genitourinary infections, and other infections (e.g., skin, bone, and dental infections)
Who takes it
Adults · Children
Adult dose
The dosage of this medicine should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the beginning of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanic acid is optimized when administered at the beginning of a meal. Adults: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate per dose orally 3 times daily, every 8 hours. The dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose for severe infections and respiratory tract infections. In patients with renal impairment, adjust the dosage appropriately according to creatinine clearance. Adults: Dosage adjustment is based on the maximum recommended dose of amoxicillin. No dosage adjustment is necessary for patients with a creatinine clearance (CrCl) of 30 mL/min or greater. 10 ~ 30 mL/min: Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours. 10 mL/min or less: Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours. Hemodialysis: Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, with an additional dose during dialysis and a repeat dose at the end of dialysis. (Because serum concentrations of both amoxicillin and clavulanic acid decrease)
Child dose
Children aged 12 years or older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. Children: Reduce the dose in the same manner.

Ingredients

Manufacturer
Teragen Etex Co., Ltd.

Efficacy & effects

Treatment of respiratory tract infections, genitourinary infections, and other infections (e.g., skin, bone, and dental infections)

  • Acute and chronic bronchitis
  • lobar pneumonia
  • bronchopneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
  • pelvic infection
View approved original text

This medication is effective in treating infections caused by various bacteria. It is widely used for respiratory infections including acute and chronic bronchitis, lobar and bronchopneumonia, sinusitis, as well as urinary tract infections such as cystitis, urethritis, and pyelonephritis. Additionally, it helps in the treatment of pelvic infections, gonorrhea, and skin/soft tissue infections like boils, abscesses, and wound infections. It is also effective for severe osteomyelitis and dental infections, making it useful for overall infection management. Considering these points, this medication significantly contributes to improving patient symptoms in response to various bacterial infections.

How to take

Adult dose

The dosage of this medicine should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the beginning of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanic acid is optimized when administered at the beginning of a meal. Adults: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate per dose orally 3 times daily, every 8 hours. The dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose for severe infections and respiratory tract infections. In patients with renal impairment, adjust the dosage appropriately according to creatinine clearance. Adults: Dosage adjustment is based on the maximum recommended dose of amoxicillin. No dosage adjustment is necessary for patients with a creatinine clearance (CrCl) of 30 mL/min or greater. 10 ~ 30 mL/min: Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours. 10 mL/min or less: Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours. Hemodialysis: Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, with an additional dose during dialysis and a repeat dose at the end of dialysis. (Because serum concentrations of both amoxicillin and clavulanic acid decrease)

Child dose

Children aged 12 years or older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. Children: Reduce the dose in the same manner.

Precautions

This medication is a beta-lactam antibiotic and should not be administered to individuals with a history of allergy to penicillin-based drugs. Particular caution is needed in cases of severe hypersensitivity reactions such as anaphylaxis, Stevens-Johnson syndrome, or shock. It should be avoided in patients with viral infections such as infectious mononucleosis or lymphocytic leukemia due to a higher risk of rash. Patients with a history of liver dysfunction or jaundice may be at risk for relapse; hence, it is better to avoid this medication. For patients with impaired liver function or severe kidney disease, dosage adjustment and careful monitoring are required due to the potential for increased drug concentration. Caution is advised for those with allergic tendencies, difficulty in oral intake, the elderly, and patients with poor overall health, as side effects like vitamin K deficiency may occur. In patients presenting gastrointestinal symptoms such as vomiting or diarrhea, careful administration is necessary as drug absorption may be impeded. This medication may cause gastrointestinal side effects, including diarrhea, vomiting, and abdominal pain, and, although rarely, serious enteritis such as pseudomembranous colitis may develop, hence immediate discontinuation is warranted on symptom occurrence. Liver function abnormalities have also been reported; therefore, regular liver function tests are needed for the elderly or those on long-term treatment. Severe skin reactions such as rash, urticaria, and in severe cases, Stevens-Johnson syndrome may occur, necessitating the immediate cessation of the medication if unusual symptoms arise. Blood-related abnormalities such as leukopenia, anemia, and thrombocytopenia have been reported rarely, and periodic blood tests may be required. Central nervous system-related adverse effects may include agitation, anxiety, confusion, and seizures; special caution is necessary for patients with compromised kidney function or those receiving high doses. Regular testing is required for kidney disease patients as this medication may affect kidney function, and treatment should be stopped in case of adverse signs. This medication can disrupt intestinal flora, leading to symptoms like candidiasis and necessitating appropriate treatment when symptoms occur. A bleeding tendency due to vitamin K deficiency may manifest, urging caution for patients at risk of bleeding. This medication may interact with other drugs; thus, consultation with a doctor during concomitant administration is advised, especially for patients on anticoagulants who should have their blood coagulation status checked regularly. The use during pregnancy should be carefully considered based on risk, and for those breastfeeding, side effects may occur in infants, necessitating the cessation of administration if adverse reactions develop. It is not recommended for children under 12 years old or those weighing less than 40 kg, and caution with dosing frequency and amount should be taken for the elderly due to decreased physiological function, increasing the risk of side effects. In case of overdose, symptoms such as gastrointestinal issues, renal failure, seizures, and hypersensitivity shock may appear, requiring immediate communication with healthcare providers for appropriate management. This medication should be stored in a dry place below 25 degrees Celsius; monitoring for the occurrence of resistant bacteria and liver or kidney function abnormalities during long-term use is important.

Side effects

Diarrhea, pseudomembranous colitis, dyspepsia, stomatitis, gastritis, glossitis, black hairy tongue, nausea, vomiting, loss of appetite, abdominal pain, abdominal distension, constipation, colonic pain, hyperacidity, loose stools, dry mouth, acute pancreatitis, candidiasis, antibiotic-associated colitis, severe colitis with bloody stools, elevated AST, elevated ALT, elevated ALP, elevated LDH, elevated serum bilirubin, hepatitis, cholestatic jaundice, itching, erythema multiforme, mucous membrane syndrome, toxic epidermal necrolysis, vesicular exfoliative dermatitis, acute generalized exanthematous pustulosis, drug reaction accompanied by eosinophilia and systemic symptoms, angioedema, anaphylaxis, serum sickness syndrome, hypersensitivity vasculitis, dyspnea with bronchospasm, laryngeal edema, anaphylactic shock, reversible leukopenia, reversible thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphocytopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, mucosal candidiasis, vaginal itching, vaginal burning, increased secretion, agitation, anxiety, behavioral changes, confusion, drowsiness, insomnia, reversible hyperactivity, dizziness, headache, convulsions, anti-parkinsonism, fever, altered consciousness, aseptic meningitis, acute renal failure, interstitial nephritis, hematuria, crystalluria, symptoms of vitamin K deficiency, symptoms of vitamin B complex deficiency, linear IgA disease, taste disturbance, malaise, dermatitis, oral edema, stomachache, fluid and electrolyte imbalance, rash, hyperactivity, drowsiness, renal failure, interstitial cerebral convulsion, hypersensitivity shock

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sealed to prevent moisture. It should be stored in a cool place between 1 to 25 degrees Celsius.

Appearance and packaging

Appearance

White to nearly white oval film-coated tablets

Package unit

40 tablets/box [(4 tablets/PTP X 10)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.